Lloyd Mitchell Segal is CEO & President at Repare Therapeutics Inc. (RPTX). They have made 12 open-market trades across 2 companies since 2012, most recently 2026-01-12.
CIK 0001477123
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $434K since 2012, against 7 sales. Across 5 scored buys the stock is up 0.2% at ninety days, and 1.1 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 80% | 80% |
| Avg Move | -13.2% | -6.4% | +0.2% |
| Alpha | -9.2% | -7.8% | -1.1% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RPTX | SELL | 2025-03-12 | 2025-03-14 | $1.14 | $24K | -6.5% | -14.1% | +34.3% |
| RPTX | SELL · 10b5-1 | 2024-03-28 | 2024-04-01 | $4.62 | $24K | -15.0% | -28.1% | -27.5% |
| RPTX | SELL · 10b5-1 | 2024-03-25 | 2024-03-27 | $4.69 | $37K | -14.9% | -30.9% | -26.3% |
| RPTX | SELL | 2021-06-28 | 2021-06-30 | $35.61 | $110K | +8.6% | +6.6% | -15.4% |
| RPTX | SELL | 2021-06-09 | 2021-06-10 | $35.00 | $55K | -3.8% | +0.8% | -5.8% |
| RPTX | SELL | 2021-06-03 | 2021-06-07 | $31.10 | $2.4M | +2.3% | -3.5% | -5.5% |
| RPTX | SELL | 2021-05-20 | 2021-05-21 | $35.03 | $264K | -9.0% | +0.1% | -5.0% |
| RPTX | SELL | 2021-05-18 | 2021-05-20 | $35.04 | $196K | -7.2% | +0.1% | -2.9% |
| RPTX | SELL | 2021-04-15 | 2021-04-19 | $35.01 | $386K | +1.2% | +5.1% | -0.6% |
| RPTX | BUY | 2020-06-23 | 2020-06-25 | $20.00 | $100K | -14.8% | -34.0% | -0.8% |
| VRX | BUY | 2013-06-14 | 2013-06-18 | $85.45 | $12K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2013-06-11 | 2013-06-13 | $84.16 | $268K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2012-11-09 | 2012-11-14 | $54.28 | $13K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2012-11-06 | 2012-11-08 | $54.44 | $41K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.